Policy for the Surgical Release of Trigger Finger Policy Number 32 (Pan Lancashire)

Similar documents
NHS Blackpool Clinical Commissioning Group (CCG) Policies for the Commissioning of Healthcare

Policies for the Commissioning of Health and Healthcare

Stage 2: eligibility screening. Stage 3: prioritisation. Stage 4: selection

NHS South Tees Clinical Commissioning Group. Governing Body. Agenda Item:

ABHI Response to the Kennedy short study on Valuing Innovation

NHS England CCG Authorisation

Gloucestershire Clinical Commissioning Group s Effective Clinical Commissioning Policies list Frequently Asked Questions

Herefordshire CCG Patient Choice and Resource Allocation Policy

Patient Choice and Resource Allocation Policy. NHS South Warwickshire Clinical Commissioning Group (the CCG)

Financial Implication Report for Ultrasound and Pulsed Electromagnetic Systems (PES) for Bone Healing

CCG Assurance and the Balanced Scorecard Balanced Scorecard An overview of the tool, and its role in CCG assurance. Khadir Meer Richard Wells

Depression in adults: treatment and management

The NHS England Assurance Framework: national report for consultation Chief Officer, Barnet Clinical Commissioning Group

Justice Select Committee: Inquiry on EU Data Protection Framework Proposals

IAPT What Now? What Next? Kevin Mullins Head of Mental Health 2 nd October 2015

Continuing Healthcare Patient Choice and Resource Allocation Policy

SAFEGUARDING ADULTS FRAMEWORK. Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services.

NHS South Kent Coast. Clinical Commissioning Group. Complaints, Comments and Compliments Policy

December Eucomed HTA Position Paper UK support from ABHI

Herts Valleys Clinical Commissioning Group. Review of NHS Herts Valleys CCG Constitution

Collaboration Agreement

Trafford CCG. CCG authorisation 360 o stakeholder survey report. Version 18 Internal Use Only Version 14 Internal Use Only

NHS CONTINUING HEALTH CARE:

13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer

An interpretation of NHS England s Primary Care Co-commissioning: Regional Roadshows questions and answers Rachel Lea, Beds & Herts LMC Ltd

Eastern Cheshire CCG CCG 360 o Stakeholder Survey

Kernow CCG CCG 360 o Stakeholder Survey

Lambeth Clinical Commissioning Group

Minimally Invasive Therapies Group

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

What to expect at your outpatient consultation. Hospitals + Health Checks + Physio + Gyms

Accountable Officer Report

Competency Standard for Registration as a Professional Engineer

Freedom of Information Act 2000 (FOIA) Decision notice

Financial Review 2013/14. Context

NHS HMR CCG and NHS England Primary Care Joint Commissioning Committee 2015/16

Swindon CCG CCG 360 o Stakeholder Survey

Southwark CCG CCG 360 o Stakeholder Survey

Early HTA to inform value driven market access and reimbursement planning

Appointment of External Auditors

Rushcliffe CCG CCG 360 o Stakeholder Survey

Development funding allocation

Centre for Healthcare Technologies

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

SHTG primary submission process

A Guide to Linked Mortality Data from Hospital Episode Statistics and the Office for National Statistics

GOVERNING BODY MEETING in Public 25 April 2018 Agenda Item 3.2

Information About Your Sigmoidoscopy

CCG 360 stakeholder survey 2017/18 National report NHS England Publications Gateway Reference: 08192

Workforce and Governing Body Members Equality Information (incorporating the WRES progress report) For further information please contact:

H5ST 04 (SCDHSC0370) Support the Use of Technological Aids to Promote Independence 1

Consumer and Community Participation Policy

CCG Assurance Framework. England

SWL Primary Care Quality, Prevention and Innovation Working Group

BOARD PAPER - NHS ENGLAND. To provide an update on discussions and actions following the authorisation and assurance committee held in October 2013.

Medtronic Payer Solutions

Merton Clinical Commissioning Group Constitution. [29 May] 2012

Ministry of Justice: Call for Evidence on EU Data Protection Proposals

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

South Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only

Get Well Soon Helping you make a speedy recovery after your Laparoscopic Nephrectomy

Portsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM. New ideas & Improvements

Information About Your Colonoscopy

Completing your Honoring Choices Health Care Directive

Sutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Freedom of Information Act 2000 (FOIA) Decision notice

Policy for CCG Engagement with the Pharmaceutical Industry

Human Factors Studies

Appendicitis a common disease

Evidence Standards and AI

Software as a Medical Device (SaMD)

CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes

Clinical Commissioning Groups: Basic decision making around delegation

Patient and Community Engagement Indicator (Compliance with statutory guidance on patient and public participation in commissioning health and care)

This factsheet covers:

EFRAG s Draft letter to the European Commission regarding endorsement of Definition of Material (Amendments to IAS 1 and IAS 8)

Notice to The Individual Signing The Power of Attorney for Health Care

FINANCE REPORT. April 2014 to December 2014

Guidance on the anonymisation of clinical reports for the purpose of publication in accordance with policy 0070

This document is a preview generated by EVS

QIPP Programme Report

Questions. Oncologist. to ask your Ventura Boulevard Tarzana, CA Questions provided by the American Cancer Society

HARROGATE AND RURAL DISTRICT CLINICAL COMMISSIONING GROUP. Minutes of the Meeting of the Harrogate and Rural District Clinical Commissioning Group

3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey

Architectural Design Sketching and Drawing

Rational Use of New Medicines

HOW TO GET SPECIALTY CARE AND REFERRALS

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Population Based Needs Assessment for Specialised Palliative Care

Clinical Commissioning Groups HR Frequently Asked Questions (FAQs)

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

Photography and Videos at School Policy

THE GRID CODE OC7.5 INTEGRAL EQUIPMENT TESTS GUIDANCE NOTES

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

When Must a Non-UH Investigator Seek Review by the UH IRB? the Issue of Engagement

AS/NZS :2017. Electrical installations Selection of cables AS/NZS :2017

Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use

Transcription:

Policy for the Surgical Release of Trigger Finger Policy Number 32 (Pan Lancashire) Version of: December 2017 Version of: November 2017 Version Number: Changes Made: 1.1 OPCS and ICD codes added to appendices 1 Pan-Lancashire and South Cumbria ratified policy Page 1 of 5

1 Introduction Policies for the Commissioning of Healthcare Policy for the Surgical Release of Trigger Finger Policy Number 32 (Pan Lancashire) 1.1 This document is part of a suite of policies that the CCG uses to drive its commissioning of healthcare. Each policy in that suite is a separate public document in its own right, but will be applied with reference to other policies in that suite. 1.2 This policy is based on the CCGs Statement of Principles for Commissioning of Healthcare (version in force on the date on which this policy is adopted). 2 Scope and definitions 2.1 Surgical release of trigger finger is a surgical procedure to treat the symptoms of trigger finger. 2.2 The scope of this policy includes requests for both percutaneous release and open surgery. 2.3 The CCG recognises that a patient may have certain features, such as having trigger finger wishing to have a service provided for trigger finger, being advised that they are clinically suitable for surgical release, and be distressed by trigger finger, and by the fact that that they may not meet the criteria specified in this commissioning policy. Such features place the patient within the group to whom this policy applies and do not make them exceptions to it. 2.4 For the purpose of this policy the CCG defines trigger finger as stenosing tenosynovitis of the digital flexor tendon (usually the thumb, ring finger or little finger) which may cause pain, clicking, finger locking and reduced range of movement 1. 3 Appropriate Healthcare 3.1 The CCG considers that the purpose of surgical release of trigger finger is to improve the health of patients by reducing pain, discomfort and disability. This places them within the category of interventions that accord with the Principle of Appropriateness in the Statement of Principles. Therefore, these procedures will be commissioned by the CCG if they also satisfy the criteria for effectiveness, cost effectiveness and ethical delivery. 4 Effective Healthcare Page 2 of 5

4.1 The CCG consider that the surgical release of trigger finger is effective in improving medium-term pain and reducing risk of recurrence compared to steroid injection 2. 4.2 The CCG recognises that major complications of surgical release are rare but evidence suggest that minor complications including pain and wound complications may occur in 28% of patients 3. 4.3 The CCG consider that the management of trigger finger should be in accordance with the British Society for Surgery of the Hand (BSSH) recommendations 4. 5 Cost Effectiveness 5.1 The CCG recognises that the outcome value for money of this treatment is within the NICE threshold and that the service satisfies the criterion of cost effectiveness. 6 Ethics 6.1 The CCG considers that the surgical release of trigger finger meets the criterion for ethical healthcare delivery. 7 Affordability 7.1 The CCG does not call into question the affordability of surgical release of trigger finger and therefore this policy does not rely on the Principle of Affordability. 8 Policy 8.1.1 The CCG will commission the surgical release of trigger finger when one or more of the following criteria are satisfied: 8.1.2 Patient has failed to respond to a single injection of steroid and local anaesthetic or it is contraindicated 8.1.3 Triggering has recurred after injection treatment 8.1.4 Patient has fixed deformity that cannot be corrected 8.2 If the policy criteria are met the CCG recognises that the type of surgical procedure (percutaneous release or open surgery) will depend on the individual patient factors including the site of the tenosynovitis (e.g. open surgery may be preferable for thumbs and cases involving the proximal interphalangeal joint 2. 9 Exceptions 9.1 The CCG will consider exceptions to this policy in accordance with the Policy for Considering Applications for Exceptionality to Commissioning Policies. This policy is based on criteria of appropriateness, effectiveness, cost effectiveness and ethical issues. A successful request to be regarded as an exception is Page 3 of 5

10 Force likely to be based on evidence that the patient differs from the usual group of patients to which the policy applies, and this difference substantially changes the application of those criteria for this patient. Requests for funding for surgical release of trigger finger under exceptional circumstances may be submitted to the CCG s Individual Funding Request Panel. 10.1 This policy remains in force until it is superseded by a revised policy or by mandatory NICE guidance relating to this intervention, or to alternative treatments for the same condition. 10.2 In the event of NICE guidance referenced in this policy being superseded by new NICE guidance, then: If the new NICE guidance has mandatory status, then that NICE guidance will supersede this policy with effect from the date on which it becomes mandatory. If the new NICE guidance does not have mandatory status, then the CCG will aspire to review and update this policy accordingly. However, until it adopts a revised policy, this policy will remain in force and any references in it to NICE guidance will remain valid as far as the decisions of this CCG are concerned. 11 References 1. NHS Choices Trigger Finger Weblink http://www.nhs.uk/conditions/trigger-finger/pages/introduction.aspx 2. J Hand Surg Eur Vol. 2011 Jan;36(1):53-6. Epub Aug 13. Percutaneous A1 pulley release vs. steroid injection for trigger digit: the results of a preospective, randomised trial 3. J Hand Surg Am. Vol 2010 Apr;35(4):594-6. Complications of open trigger release. 4. The British Society for Surgery of the Hand (2016) Evidence based management of adult trigger fingers. Available at: http://www.bssh.ac.uk/_userfiles/pages/files/professionals/best%20 Guidelines/BEST%20trigger%20finger%20PUBLISHED.pdf (Accessed: 14 December 2016). Date of adoption: 02 November 2017 Date for review: 02 November 2020 Appendix 1 1.1 Codes The codes applicable to this policy are: OPCS codes T652, T658, T659, T691, T698, T699, T705, T708, T709, T711, T718, T719, T721, T723, T724, T728, T729, T743, T748, T749 ICD codes M653 Page 4 of 5

Page 5 of 5